Skip to content
Disclosery

13F-HR filed by SUPERSTRING CAPITAL MANAGEMENT LP

SUPERSTRING CAPITAL MANAGEMENT LP filed this 13F-HR for the quarter ended 2026-03-31, filed 2026-05-14, with 35 holding rows worth $139,969,967.

Accession
0001931118-26-000008
Filer
CIK 1931118
Filed
2026-05-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2026

A holdings report, 35 entries on the cover page, a total value of $139,969,967 stated on the cover page (in dollars after the unit check, H1), rows summing to $139,969,967 with VALUE read as dollars as filed, 13F file number 028-23866. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
SUMMIT THERAPEUTICS INC86627T108COM892,873$16,928,872dollars as filed
IMMUNOVANT INC45258J102COM357,606$8,882,933dollars as filed
COGENT BIOSCIENCES INC19240Q201COM225,158$8,666,331dollars as filed
SAVARA INC805111101COM1,585,977$8,659,434dollars as filed
UROGEN PHARMA LTDM96088105COMMON STOCK387,371$6,964,931dollars as filed
DEFINIUM THERAPEUTICS INC24477V105COM SHS351,461$6,642,613dollars as filed
VIR BIOTECHNOLOGY INC92764N102COM730,548$6,545,710dollars as filed
VAXCYTE INC COM92243G108Stock110,454$6,418,482dollars as filed
CELLDEX THERAPEUTICS INC NEW15117B202COM NEW180,048$5,711,123dollars as filed
SIONNA THERAPEUTICS INC829401108COMMON STOCK141,024$5,653,652dollars as filed
GENMAB A/S372303206Ordinary Shares, nominal value DKK 1 per share196,709$5,277,702dollars as filed
ZAI LAB LTD ADR98887Q104ADR275,818$5,188,137dollars as filed
Vertex Pharmaceuticals Incorporated92532F100COM11,010$4,916,405dollars as filed
IQVIA HLDGS INC COM46266C105Stock25,668$4,377,421dollars as filed
MAPLIGHT THERAPEUTICS INC56565P103COMMON STOCK192,139$3,906,186dollars as filed
ARVINAS INC04335A105COM312,620$3,313,772dollars as filed
ORUKA THERAPEUTICS INC COM687604108Stock63,591$3,119,139dollars as filed
UNITED THERAPEUTICS CORP DEL COM91307C102Stock5,186$3,075,194dollars as filed
TRAVERE THERAPEUTICS INC89422G107COM102,754$3,052,821dollars as filed
TREVI THERAPEUTICS INC COM89532M101Stock251,566$3,001,182dollars as filed
Adlai Nortye00704R109SPONSORED ADS414,852$2,870,776dollars as filed
CABALETTA BIO INC12674W109COMMON STOCK1,066,239$2,868,183dollars as filed
Pfizer Inc.717081103COM74,000$2,077,920dollars as filed
AXSOME THERAPEUTICS INC. COM05464T104Stock11,217$1,895,897dollars as filed
ORIC PHARMACEUTICALS INC68622P109COM115,234$1,460,015dollars as filed
ACLARIS THERAPEUTICS INC COM00461U105Stock366,490$1,374,338dollars as filed
CLIMB BIO INC28658R106COMMON STOCK199,209$1,364,582dollars as filed
TAYSHA GENE THERAPIES INC877619106COMMON STOCK258,269$1,154,462dollars as filed
BRIGHT MINDS BIOSCIENCES INC10919W405COMMON STOCK13,311$971,304dollars as filed
TONIX PHARMACEUTICALS HOLDIN890260839COMMON STOCK63,540$873,675dollars as filed
CULLINAN THERAPEUTICS INC230031106COM59,484$845,268dollars as filed
PROTARA THERAPEUTICS INC74365U107COM STK121,457$632,791dollars as filed
PALATIN TECHNOLOGIES INC696077601COM NEW35,969$626,580dollars as filed
BIOMEA FUSION INC09077A106CMN250,000$382,500dollars as filed
CENTURY THERAPEUTICS INC15673T100COM119,308$269,636dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001931118-26-000008this filing2026-05-14acceptance time not in the bulk data set